W. H. Greene, M.D.; S. C. Schimpff, M.D.; V. M. Young, M.D.; P. H. Wiernik, M.D.
This content is PDF only. Please click on the PDF icon to access.
The use of empiric, broad-spectrum antibiotic therapy in the treatment of presumed Gram-negative sepsis is nowhere more necessary than in the granulocytopenic patient, for without such therapy early (48 to 72 hours) death rates may exceed 50%. Since February 1971 the combination of carbenicillin, gentamicin, and cephalothin has been empirically applied to granulocytopenic (less than 1500/mm3), febrile (more than 38.3 °C [101 °F]) cancer patients at the first clinical suspicion of sepsis. In the ensuing 18 months 89 patients were treated for 177 such episodes, of which 103 were evaluable. (Nonevaluability was equated with either nonbacterial infection or no demonstrable
W. H. Greene, S. C. Schimpff, V. M. Young, P. H. Wiernik. Empiric Carbenicillin, Gentamicin and Cephalothin Therapy for Presumed Infection in Patients with Granulocytopenia and Cancer.. Ann Intern Med. 1973;78:825–826. doi: 10.7326/0003-4819-78-5-825_4
Download citation file:
Published: Ann Intern Med. 1973;78(5):825-826.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use